AssureStart Appoints Sheryl Medeiros as General Counsel
Proquest LLC
AssureStart has appointed Sheryl Medeiros as general counsel.
According to a company release, in her new role, Medeiros will oversee all company legal, regulatory and compliance matters. She also will participate on AssureStart's business development team.
Medeiros previously was executive vice president at United Guaranty (UGC), where she played a key role in the turnaround of the company's mortgage insurance business from 2009-2013. During that time, Medeiros served as general counsel, with responsibility for UGC's global legal, regulatory, compliance and government affairs functions, and chief executive officer of UGC's international business.
"We are excited to welcome Sheryl to AssureStart," said Greg Tacchetti, AssureStart president and CEO. "Sheryl brings a wealth of legal and management experience to the team. She will be a major contributor as we continue our national expansion - both in terms of our service footprint and our strategic distribution partnerships."
Advisor News
- Global economic growth will moderate as the labor force shrinks
- Estate planning during the great wealth transfer
- Main Street families need trusted financial guidance to navigate the new Trump Accounts
- Are the holidays a good time to have a long-term care conversation?
- Gen X unsure whether they can catch up with retirement saving
More Advisor NewsAnnuity News
- Prudential launches FlexGuard 2.0 RILA
- Lincoln Financial Introduces First Capital Group ETF Strategy for Fixed Indexed Annuities
- Iowa defends Athene pension risk transfer deal in Lockheed Martin lawsuit
- Pension buy-in sales up, PRT sales down in mixed Q3, LIMRA reports
- Life insurance and annuities: Reassuring ‘tired’ clients in 2026
More Annuity NewsHealth/Employee Benefits News
Life Insurance News
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on Malaysia’s Non-Life Insurance Segment
- Report Summarizes Kinase Inhibitors Study Findings from Saga University Hospital (Simulation of Perioperative Ibrutinib Withdrawal Using a Population Pharmacokinetic Model and Sparse Clinical Concentration Data): Drugs and Therapies – Kinase Inhibitors
- Flawed Social Security death data puts life insurance benefits at risk
- EIOPA FLAGS FINANCIAL STABILITY RISKS RELATED TO PRIVATE CREDIT, A WEAKENING DOLLAR AND GLOBAL INTERCONNECTEDNESS
- Envela partnership expands agent toolkit with health screenings
More Life Insurance News